The 4th Schizophrenia International Research Society Conference was held in Florence, Italy, April 5-9, 2014 and this year had as its emphasis, "Fostering Collaboration in Schizophrenia Research". Student travel awardees served as rapporteurs for each oral session, summarized the important contributions of each session and then each report was integrated into a final summary of data discussed at the entire conference by topic. It is hoped that by combining data from different presentations, patterns of interest will emerge and thus lead to new progress for the future. In addition, the following report provides an overview of the conference for those who were present, but could not participate in all sessions, and those who did not have the opportunity to attend, but who would be interested in an update on current investigations ongoing in the field of schizophrenia research.

Centre for Youth Mental Health The University of Melbourne 35 Poplar Road Parkville 3052 Victoria Australia

Child and Adolescent Psychiatry Department Hospital General Universitario Gregorio Marañón School of Medicine Universidad Complutense IiSGM CIBERSAM C Ibiza 43 28009 Madrid Spain

Cognition and Schizophrenia Imaging Laboratory Institute of Psychiatry King's College 16 De Crespigny Park Rd Denmark Hill London SE5 8AF UK

Departament de Psicologia Clínica i de la Salut Universitat Autònoma de Barcelona Edifici B 08193 Bellaterra Barcelona Spain

Department of Neuroscience A210 Langley Hall University of Pittsburgh Pittsburgh PA 15260 United States

Department of Psychiatry and Psychotherapy Friedrich Alexander University of Erlangen Nuremberg Ulmenweg 19 91054 Erlangen Germany

Department of Psychiatry Faculty of Medicine and Health Sciences Stellenbosch University Tygerberg Cape Town South Africa

Department of Psychiatry Faculty of Medicine Chiang Mai University Chiang Mai 50200 Thailand

Department of Psychiatry Harvard Medical School 940 Belmont Street Brockton MA 02301 United States; VA Boston Healthcare System 940 Belmont Street Brockton MA 02301 United States

Department of Psychiatry Psychotherapy and Medical Psychology of Stavropol State Medical University 28b Aivazovsky str Stavropol 355007 Russia

Department of Psychosis Studies Institute of Psychiatry King's College London 16 De Crespigny Park SE5 8AF London UK

Government College University 170 S 19 B College Road New Samanabad Lahore Pakistan

Harvard Medical School Brockton MA 02301 United States

Health Services and Population Research Department David Goldberg Centre Institute of Psychiatry De Crespigny Park Denmark Hill London SE5 8AF UK

Howard University College of Medicine 520 W Street Washington DC 20059 United States

Laboratory of Molecular Psychiatry INCT for Translational Medicine Hospital de Clínicas de Porto Alegre Universidade Federal do Rio Grande do Sul Rua Ramiro Barcelos 2350 Santa Cecília Porto Alegre RS 90035 903 Brazil

Laboratory of System and Cell Biology of Neurodegeneration University of Zurich Wagistrasse 12 8952 Schlieren Zurich Switzerland

Ladoke Akintola University of Technology Teaching Hospital PMB 4007 Ogbomoso Oyo Nigeria

Maryland Psychiatric Research Center Department of Psychiatry University of Maryland School of Medicine Neuroimaging Research Program P O Box 21247 Baltimore MD 21228 United States

Mental Health Centre Copenhagen Bispebjerg Bakke 23 Entrance 13A 3rd floor DK 2400 Copenhagen NV Denmark

Morehouse School of Medicine 720 Westview Dr SW Atlanta GA 30310 United States

Moscow Research Institute of Psychiatry Russian Federation Prague Psychiatric Centre affiliated with 3rd Faculty of Medicine Charles University Prague Czech Republic

National Institute of Mental Health and Neurosciences Bengaluru India

Neuropsychology and Applied Cognitive Neuroscience Laboratory Key Laboratory of Mental Health Institute of Psychology Chinese Academy of Sciences 16 Lincui Road Beijing 100101 China

Pharmacology Department Basic Health Sciences Institute Universidade Federal do Rio Grande do Sul Rua Sarmento Leite 500 90050 170 Porto Alegre RS Brazil

Saw Swee Hock School of Public Health National University of Singapore MD3 16 Medical Drive Singapore 117597 Singapore

Sheba Medical Center Ramat Gan Israel

Shefa Neuroscience Research Center Tehran Iran

The Florey Institute of Neuroscience and Mental Health Kenneth Myer Building 30 Royal Parade Parkville 3052 VIC Australia

University of Texas Medical Branch School of Medicine 215 Mechanic Street Apt M206 Galveston77550 TX United States

Wayne State University School of Medicine 469 West Hancock Detroit 48201 MI United States

See more in PubMed

Aas M, Haukvik UK, Djurovic S, et al. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:181–188. PubMed

Abbs B1, Achalia RM, Adelufosi AO, et al. The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res. 2012 Oct;141(1):e1–e24. doi: 10.1016/j.schres.2012.07.024. 2012. Epub 2012 Aug 19. PubMed DOI PMC

Abubaker R, Alaerts M, Allman AA, et al. Summary of the 1st Schizophrenia International Research Society Conference oral sessions, Venice, Italy, June 21–25, 2008: the rapporteur reports. Schizophr Res. 2008 Feb;107(2–3):337. 2009. PubMed

Abi-Dargham A, Mawlawi O, Lombardo I, et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002;22(9):3708–3719. PubMed PMC

Aleman AF, de Haan EH, Castner SA, et al. Antipsychotics and working memory in schizophrenia. Science. 2000;289(5476):56b–58b. PubMed

Alexander-Bloch AF, Reiss PT, Rapoport J, et al. Abnormal Cortical Growth in Schizophrenia Targets Normative Modules of Synchronized Development. Biol Psychiatry. 2014 doi: 10.1016/j.biopsych.2014.02.010. PubMed DOI PMC

Allen EA, Damaraju E, Plis SM, et al. Tracking whole-brain connectivity dynamics in the resting state. Cereb Cortex. 2014;24(3):663–676. PubMed PMC

Alonso G, Casati F, Kuno H, Machiraju V. Web services. Springer; 2004.

Alvarez-Jimenez M, Gleeson JF, Henry LP, et al. Prediction of a single psychotic episode: A 7.5-year, prospective study in first-episode psychosis. Schizophrenia Research. 2011;125(2–3):236–246. PubMed

Amminger G, Schäfer MR, Papageorgiou K, et al. Long-chain ω-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Archives of General Psychiatry. 2010;67(2):146–154. PubMed

Anderson KK, Flora N, Archie S, et al. Race, ethnicity, and the duration of untreated psychosis:a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2013 (epub ahead of print) PubMed

Baharnoori M, Bartholomeusz C, Boucher AA, et al. The 2nd Schizophrenia International Research Society Conference, 10–14 April 2010, Florence, Italy: Summaries of oral sessions. Schizophr Res. 2010 doi: 10.1016/j.schres.2010.09.008. PubMed DOI PMC

Bechdolf A, Thompson A, Nelson B, et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand. 2010;121(5):377–384. PubMed

Bloomfield MA, Morgan CJ, Egerton A, et al. Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms. Biol Psychiatry. 2013 doi: 10.1016/j.biopsych.2013.05.027. PubMed DOI

Blumberger DM, Fitzgerald PB, Mulsant BH, Daskalakis ZJ. Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia. Curr Opin Psychiatry. 2010;23(2):85–90. PubMed

Bola JR, Kao DT, Soydan H. Antipsychotic medication for early-episode schizophrenia. Schizophr Bull. 2012;38(1):23–5. PubMed PMC

Brown AS, Derkits EJ. Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies. American Journal of Psychiatry. 2010;167:261–280. PubMed PMC

Brunelin J, Mondino M, Gassab L, et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012;169(7):719–724. PubMed

Buckner RL, Sepulcre J, Talukdar T, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci. 2009;29:1860–73. doi: 10.1523/JNEUROSCI.5062-08.2009. PubMed DOI PMC

Camargo LM, Collura V, Rain JC, et al. Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry. 2007;12(1):74–86. PubMed

Carpenter WT, Jr, Appelbaum PS, Levine RJ. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. Am J Psychiatry. 2003;160:356–362. PubMed

Collin G, Kahn RS, de Reus MA, et al. Impaired rich club connectivity in unaffected siblings of schizophrenia patients. Schizophr Bull. 2014;40(2):438–48. PubMed PMC

Correll CU. Acute and long-term adverse effects of antipsychotics. CNS Spectr. 2007;12(12):10–14. PubMed

Correll CU, Manu P, Olshanskiy V, et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765–1763. PubMed PMC

Creamer MC, Burgess P, McFarlane AC. Post-traumatic stress disorder: findings from the Australian National Survey of Mental Health and Well-being. Psychol Med. 2001;31(7):1237–47. PubMed

Cropley V, Wood SJ, Pantelis C. Brain structural, neurochemical and neuroinflammatory markers of psychosis onset and relapse: Is there evidence for a psychosis relapse signature? International Clinical Psychopharmacology. 2013 Publish Ahead of Print. PubMed

De Hert M, Detraux J, van Winkel R, et al. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011;8(2):114–126. PubMed

Demjaha A, Murray RM, McGuire PK, et al. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry. 2012;169(11):1203–1210. PubMed

Di Forti M, Salis H, Allegri F, et al. Daily Use, Especially of High-Potency cannabis, drives the earlier Onset of psychosis in Cannabis Users. Schizophrenia Bulletin. 2013 doi: 10.1093/schbul/sbt181. PubMed DOI PMC

Dodd S, Maes M, Anderson G, et al. Putative neuroprotective agents in neuropsychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013;42(0):135–145. PubMed

Dutta R, Murray RM, Allardyce J, et al. Early risk factors for suicide in an epidemiological first episode psychosis cohort. Schizophr Res. 2011;126(1–3):11–19. PubMed

Dutta R, Murray RM, Hotopf M, et al. Reassessing the long-term risk of suicide after a first episode of psychosis. Arch Gen Psychiatry. 2010;67(12):1230–1237. PubMed

Egerton A, Chaddock CA, Winton-Brown TT, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry. 2013;74(2):106–112. PubMed

Emsley R, Fleischhacker WW. Is the ongoing use of placebo in relapse-prevention clinical trials in schizophrenia justified? Schizophr Res. 2013;150(2–3):427–433. PubMed

Etain B, Aas M, Andreassen OA, et al. Childhood trauma is associated with severe clinical characteristics of bipolar disorders. J Clin Psychiatry. 2013;74(10):991–998. PubMed

Etain B, Mathieu F, Henry C, et al. Preferential association between childhood emotional abuse and bipolar disorder. J Trauma Stress. 2010;23(3):376–383. PubMed

Flatscher-Bader T, Foldi CJ, Chong S, et al. Increased de novo copy number variants in the offspring of older males. Translational Psychiatry. 2011;1:e34. PubMed PMC

Flores BJ, Kenna H, Keller J, et al. Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression. Neuropsychopharmacology. 2006;31:628–636. PubMed

Fornito A, Yücel M, Patti J, et al. Mapping grey matter reductions in schizophrenia: An anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophrenia Research. 2009;108(1–3):104–113. PubMed

Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506(7487):179–84. PubMed PMC

Fung SJ, Webster MJ, Sivagnanasundaram S, et al. Expression of Interneuron Markers in the Dorsolateral Prefrontal Cortex of the Developing Human and in Schizophrenia. Am J Psychiatry. 2010;167(12):1479–88. PubMed

Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012a;69(3):220–229. PubMed

Fusar-Poli P, Carpenter WT, Woods SW, McGlashan TH. Attenuated Psychosis Syndrome: Ready for DSM-5.1? Annu Rev Clin Psychol. 2014;10:155–192. PubMed

Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical Maps of Psychosis Onset: Voxel-wise Meta-Analysis of Antipsychotic-Naive VBM Studies. Schizophrenia Bulletin. 2012b;38(6):1297–1307. PubMed PMC

Gaebel W, Riesbeck M. Are there clinically useful predictors and early warning signs for pending relapse? Schizophr Res. 2014;152(2–3):469–477. PubMed

Gaebel W, Riesbeck M, Wolwer W, et al. Relapse prevention in first-episode schizophrenia–maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry. 2011;72(2):205–218. PubMed

Garver DL, Nair TR, Christensen JD, et al. Brain and ventricle instability during psychotic episodes of the schizophrenias. Schizophrenia Research. 2000;44(1):11–23. PubMed

Gillis J, Pavlidis P. The impact of multifunctional genes on “guilt by association” analysis. PLoS One. 2011;6(2):e17258. PubMed PMC

Gillis J, Pavlidis P. “Guilt by association” is the exception rather than the rule in gene networks. PLoS Comput Biol. 2012;8(3):e1002444. PubMed PMC

Golenkov A, Tsymbalova A, Large M, Nielssen O. An international perspective on homicide and schizophrenia: a study from Chuvashia. Schizophr Res. 2011;131(1–3):258–259. PubMed

Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci. 2008;9(7):568–578. PubMed PMC

Guha S, Rees E, Darvasi A, et al. Implication of a rare deletion at distal 16p11.2 in schizophrenia. JAMA psychiatry. 2013;70:253–60. doi: 10.1001/2013.jamapsychiatry.71. PubMed DOI PMC

Gutiérrez-Galve L, Wheeler-Kingshott CA, Altmann DR, et al. Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis. Biol Psychiatry. 2010;68(1):51–60. PubMed PMC

Haijma SV, Van Haren N, Cahn W, et al. Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects. Schizophrenia Bulletin. 2013;39(5):1129–1138. PubMed PMC

Hammer C, Stepniak B, Schneider A, et al. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Molecular psychiatry. 2013 Sep 3; doi: 10.1038/mp.2013.110. 2013. PubMed DOI

Hatada S, Sawada K, Akamatsu M, et al. Impaired musical ability in people with schizophrenia. J Psychiatry Neurosci. 2014;39(2):118–126. PubMed PMC

Heinz A, Schlagenhauf F. Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited. Schizophrenia Bulletin. 2010;36(3) PubMed PMC

Hennah W, Porteous D. The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. PLoS One. 2009;4(3):e4906. PubMed PMC

Hill M, Crumlish N, Clarke M, et al. Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years. Schizophrenia Research. 2012;141(2–3):215–221. PubMed

Homan P, Vermathen P, Van Swam C, et al. Magnetic resonance spectroscopy investigations of functionally defined language areas in schizophrenia patients with and without auditory hallucinations. Neuroimage. 2014;94:23–32. PubMed

Howes OD, Bose SK, Turkheimer F, et al. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry. 2011;168(12):1311–1317. PubMed PMC

Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry. 2009;66(1):13–20. PubMed

Howes OD, Williams M, Ibrahim K, et al. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 2013;136(11):3242–3251. PubMed PMC

Howgego I, Owen C, Meldrum L, et al. Posttraumatic stress disorder: An exploratory study examing rates of trauma and PTSD and its effect on client outcomes in community mental health. BMC psychiatry. 2005;5(1):21. PubMed PMC

Insel TR. Rethinking Schizophrenia. Nature. 2010;468:187–193. PubMed

Inta D, Meyer-Lindenberg A, Gass P. Alterations in Postnatal Neurogenesis and Dopamine Dysregulation in Schizophrenia: A Hypothesis. Schizophr Bull. 2011;37(4):674–80. PubMed PMC

Ivleva EI, Bidesi AS, Keshavan MS, et al. Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) Am J Psychiatry. 2013;170(11):1285–1296. PubMed PMC

Joshi D, Fung SJ, Rothwell A, et al. Higher Gamma-Aminobutyric Acid Neuron Density in the White Matter of Orbital Frontal Cortex in Schizophrenia. Biol Psychiatry. 2012;72(9):725–33. PubMed

Keefe RSE. Cognitive Deficits in Patients With Schizophrenia: Effects and Treatment. J Clin Psychiatry. 2007;68(4):8–13. PubMed

Kelleher I, Cederlöf M, Lichtenstein P. Psychotic experiences as a predictor of the natural course of suicidal ideation: a Swedish cohort study. World Psychiatry in press. PubMed PMC

Kelleher I, Corcoran P, Keeley H, et al. Psychotic symptoms and population risk for suicide attempt: a prospective cohort study. JAMA Psychiatry. 2013a;70(9):940–948. PubMed

Kelleher I, Devlin N, Wigman JTW, et al. Psychotic experiences in a mental health clinic sample: implications for suicidality, multimorbidity and functioning. Psychol Med. 2013b http://dx.doi.org/10.1017/S0033291713002122. PubMed DOI

Kelleher I, Keeley H, Corcoran P, et al. Childhood trauma and psychosis in a prospective cohort study: cause, effect, and directionality. Am J Psychiatry. 2013c;170:734–741. PubMed

Kelleher I, Lynch F, Harley M, et al. Psychotic symptoms in adolescence index risk for suicidal behavior: findings from 2 population-based case-control clinical interview studies. Arch Gen Psychiatry. 2012;69(12):1277–1283. PubMed

Kellendonk C, Simpson EH, Polan HJ, et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron. 2006;49(4):603–15. PubMed

Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry. 2005;62(6):617–27. PubMed PMC

Kirov G, Pocklington AJ, Holmans P, et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry. 2012;17(2):142–53. PubMed PMC

Korver N, Quee PJ, Boos HB, et al. Genetic Risk and Outcome of Psychosis (GROUP), a multi-site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. Int J Methods Psychiatr Res. 2012;21(3):205–221. PubMed PMC

Koutsouleris N, Davatzikos C, Borgwardt S, et al. Accelerated brain aging in schizophrenia and beyond: a neuroanatomical marker of psychiatric disorders. Schizophr Bull. 2013;13 doi: 10.1093/schbul/sbt142. PubMed DOI PMC

Li P, Zhang Q, Robichaud AJ, et al. Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders. J Med Chem. 2014;57(6):2670–2682. PubMed

Lieberman JA, Dunbar G, Segreti AC, et al. A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology. 2013;38(6):968–975. PubMed PMC

Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A. 2004;101:9861–9866. PubMed PMC

Mackay-Sim A. Patient-Derived Stem Cells: Pathways to Drug Discovery for Brain Diseases. Front Cell Neurosci. 2013;7:29. PubMed PMC

Mancuso F, Horan WP, Kern RS, Green MF. Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res. 2011;125(3):143–151. PubMed PMC

Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first episode patients:a systematic review. Arch Gen Psychiatry. 2005;62(9):975–83. PubMed

Martin-Facklam M, Pizzagalli F, Zhou Y, et al. Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers. Neuropsychopharmacology. 2013;38(3):504–12. PubMed PMC

Martins-de-Souza D, Gattaz WF, Schmitt A, et al. Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J Psychiatr Res. 2009;43:978–986. PubMed

McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet. 2009;41:1223–7. doi: 10.1038/ng.474. PubMed DOI PMC

McGorry PD, Nelson B, Phillips LJ, et al. Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry. 2013;74(4):349–356. PubMed

Miller B, Messias E, Miettunen J, et al. Meta-analysis of Paternal Age and Schizophrenia Risk in Male Versus Female Offspring. Schizophrenia Bulletin. 2011;37(5) PubMed PMC

Mistry M, Gillis J, Pavlidis P. Meta-analysis of gene coexpression networks in the post-mortem prefrontal cortex of patients with schizophrenia and unaffected controls. BMC Neurosci. 2013;14:105. PubMed PMC

Moilanen J, Haapea M, Miettunen J, et al. Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication – a 10-year follow-up of the Northern Finland 1966 Birth Cohort study. Eur Psychiatry. 2013;28(1):53–58. PubMed

Morrison AP, Birchwood M, Pyle M, et al. Impact of cognitive therapy on internalised stigma in people with at-risk mental states. Br J Psychiatry. 2013;203(2):140–145. PubMed

Morrison AP, Turkington D, Pyle M, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. The Lancet. 2014;383(9926):1395–403. PubMed

Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? British medical journal (Clinical research ed) 1987;295(6600):681. PubMed PMC

Nanda P, Tandon N, Mathew IT, et al. Local gyrification index in probands with psychotic disorders and their first-degree relatives. Biol Psychiatry. 2013;23 pii.S0006-3223 (13) 01030–5. PubMed PMC

Nielsen RE. Cognition in schizophrenia – a systematic review. Drug Discovery Today: Therapeutic Strategies. 2011;8(1):1–2.

Nielsen ON, Rostrup E, Wulff S, et al. Alterations of the Brain Reward System in Antipsychotic Naïve Schizophrenia Patients. Biol Psychiatry. 2012a;71:898–905. PubMed

Nielsen MO, Rostrup E, Wulff S, et al. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry. 2012b;69:1195–1204. PubMed

Nielsen J, Skadhede S, Correll CU. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients. Neuropsychopharmacology. 2010;35(9):1997–2004. PubMed PMC

Nielssen OB, Yee NL, Millard MM, Large MM. Comparison of first-episode and previously treated persons with psychosis found NGMI for a violent offense. Psychiatr Serv. 2011;62(7):759–764. PubMed

Nieman DH, Ruhrmann S, Dragt S, et al. Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables. Schizophr Bull. 2013 http://dx.doi.org/10.1093/schbul/sbt145. PubMed DOI PMC

Nieuwenhuis M, van Haren NEM, Hulshoff Pol HE, et al. Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. NeuroImage. 2012;61(3):606–612. PubMed

Niu J, Mei F, Li N, et al. Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell cultures. Biochem Cell Biol. 2010;88:611–620. PubMed

Øie M, Sundet K, Rund BR. Neurocognitive decline in early-onset schizophrenia compared with ADHD and normal controls: evidence from a 13-year follow-up study. Schizophr Bull. 2010;36(3):557–65. PubMed PMC

Ozaita A, Puighermanal E, Maldonado R. Regulation of PI3k/AKT/GSK-3 pathway by Cannabinoids in the brain. Journal of Neurochemistry. 2007 doi: 10.1111/j.1471-4159.2007.04642.x. PubMed DOI

Pantelis C, Yücel M, Wood SJ, et al. Structural Brain Imaging Evidence for Multiple Pathological Processes at Different Stages of Brain Development in Schizophrenia. Schizophrenia Bulletin. 2005;31(3):672–696. PubMed

Petersen L, Mortensen PB, Pedersen CB. Paternal Age at Birth of First Child and Risk of Schizophrenia. American Journal of Psychiatry. 2011;168(1):82–88. PubMed

Power JD, Cohen AL, Nelson SM, et al. Functional Network Organization of the Human Brain. Neuron. 2011;72(4):665–678. PubMed PMC

Purcell SM, Moran JL, Fromer M, et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014;506:185–90. doi: 10.1038/nature12975. PubMed DOI PMC

Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170(1):59–70. PubMed

Repovš G, Barch DM. Working memory related brain network connectivity in individuals with schizophrenia and their siblings. Front Hum Neurosci. 2012;6:137. doi: 10.3389/fnhum.2012.00137. PubMed DOI PMC

Rietdijk J, Klaassen R, Ising H, et al. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatr Scand. 2012;126(1):21–30. PubMed

Ripke S, O’Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150–9. doi: 10.1038/ng.2742. PubMed DOI PMC

Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five new schizophrenia loci. Nat Genet. 2011;43:969–76. doi: 10.1038/ng.940. PubMed DOI PMC

Rocha-Rego V, Jogia J, Marquand AF, et al. Examination of the predictive value of structural magnetic resonance scans in bipolar disorder: a pattern classification approach. Psychological Medicine. 2014;44(03):519–532. PubMed PMC

Roussos P, Katsel P, Davis KL, et al. Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry. 2012;69:7–15. PubMed

Rubinov M, Bullmore E. Schizophrenia and abnormal brain network hubs. Dialogues Clin Neurosci. 2013;15:339–49. PubMed PMC

Sandhu A, Ives J, Birchwood M, Upthegrove R. The subjective experience and phenomenology of depression following first episode psychosis: a qualitative study using photo-elicitation. J Affect Disord. 2013;149(1–3):166–174. PubMed

Schneider M, Debbané M, Bassett AS, et al. Psychiatric Disorders From Childhood to Adulthood in 22q11.2 Deletion Syndrome: Results From the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry. 2014 doi: 10.1176/appi.ajp.2013.13070864. PubMed DOI PMC

Selten JP, Cantor-Graae E. Social Defeat: Risk Factor for Schizophrenia? Br J Psychiatry. 2005;187:101–2. PubMed

Simpson EH, Kellendonk C, Ward RD, et al. Pharmacologic rescue of motivational deficit in an animal model of the negative symptoms of schizophrenia. Biol Psychiatry. 2011;69(10):928–35. PubMed PMC

Skudlarski P, Schretlen DJ, Thaker GK, et al. Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry. 2013;170(8):886–898. PubMed

Smeets F, Lataster T, Dominguez MG, et al. Evidence That Onset of Psychosis in the Population Reflects Early Hallucinatory Experiences That Through Environmental Risks and Affective Dysregulation Become Complicated by Delusions. Schizophrenia Bulletin. 2012;38(3):531–542. PubMed PMC

Smeets F, Lataster T, Dominguez M, et al. Evidence That Onset of Psychosis in the Population Reflects early Hallucinatory Experiences That Through Environmental risks and Affective Dysregulation become complicated by Delusions. Schizophrenia Bulletin. 2010 doi: 10.1093/schibul/sbq/117. PubMed DOI PMC

Song XQ, Lv LX, Li WQ, et al. The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia. Biological Psychiatry. 2009;65:481–488. PubMed

Sprooten E, Papmeyer M, Smyth AM, et al. Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison. Schizophr Res. 2013;151:259–264. PubMed

Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA psychiatry. 2013;70(3):271–278. PubMed

Takahashi K, Yamanaka S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell. 2006;126(4):663–76. PubMed

Takahashi T, Wood SJ, Yung AR, et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Archives of General Psychiatry. 2009;66(4):366–376. PubMed

Thompson AD, Nelson B, Yuen HP, et al. Sexual trauma increases the risk of developing psychosis in an ultra high-risk “prodromal” population. Schizophr Bull. 2014;40(3):697–706. PubMed PMC

Thompson J, Urban N, Slifstein M, et al. Striatal dopamine release in schizophrenia comorbid with substance dependence. Molecular psychiatry. 2013;18:909–915. PubMed PMC

Thomson PA, Parla JS, McRae AF, et al. 708 Common and 2010 rare DISC1 locus variants identified in 1542 subjects; analysis for association with psychiatric disorder and cognitive traits. Mol Psychiatry. 2014;19:668–675. doi: 10.1038/mp.2013.68. PubMed DOI PMC

Trifilieff P, Feng B, Urizar E, et al. Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol Psychiatry. 2013;18(9):1025–33. PubMed PMC

Unschuld PG, Buchholz AS, Varvaris M, et al. Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction. Schizophr Bull. 2014;40(3):653–664. PubMed PMC

Upthegrove R, Birchwood M, Ross K, et al. The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 2010;122(3):211–218. PubMed

Upthegrove R, Ross K, Brunet K, et al. Depression in first episode psychosis: the role of subordination and shame. Psychiatry Res. 2014 http://dx.doi.org/10.1016/j.psychres.2014.03.023. PubMed DOI

Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment. 2011;2011325789 PubMed PMC

Vacic V, McCarthy S, Malhotra D, et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature. 2011;471:499–503. doi: 10.1038/nature09884. PubMed DOI PMC

Van den Heuvel MP, Sporns O, Collin G, et al. Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA psychiatry. 2013;70:783–92. doi: 10.1001/jamapsychiatry.2013.1328. PubMed DOI

van Os J, Linscott RJ. Introduction: The extended psychosis phenotype–relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophr Bull. 2012;38(2):227–230. PubMed PMC

van Os J, Murray RM. Can we identify and treat “schizophrenia light” to prevent true psychotic illness? BMJ. 2013;346:f304. PubMed

Van Winkel R, Beveren N, Simons C, (GROUP), G. R. a. O. o. p AKT1 Moderation of Cannabis-Induced Cognitive Aletrations in Psychotic Disorder. Neuropsychopharmacology. 2011;36:2529–2537. PubMed PMC

van NM, Lataster T, Smeets F, et al. Psychopathological mechanisms linking childhood traumatic experiences to risk of psychotic symptoms: analysis of a large, representative population-based sample. Schizophr Bull. 2014;40(Suppl 2):S123–S130. PubMed PMC

Velakoulis D, Wood SJ, Wong MH, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: A magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra–high-risk individuals. Archives of General Psychiatry. 2006;63(2):139–149. PubMed

Velthorst E, Nelson B, O’Connor K, et al. History of trauma and the association with baseline symptoms in an Ultra-High Risk for psychosis cohort. Psychiatry Res. 2013;210(1):75–81. PubMed

Vernon AC, Crum WR, Lerch JP, et al. Reduced Cortical Volume and Elevated Astrocyte Density in Rats Chronically Treated with Antipsychotic Drugs-Linking Magnetic Resonance Imaging Findings to Cellular Pathology. Biol Psychiatry. 2014 Jun 15;75(12):982–90. 2014. PubMed

Vernon AC, Natesan S, Crum WR, et al. Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation. Biol Psychiatry. 2012;71(10):855–63. PubMed

Vernon AC, Natesan S, Modo M, Kapur S. Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation. Biol Psychiatry. 2011;69(10):936–44. PubMed

Walther S, Strik W. Motor Symptoms and Schizophrenia. Neuropsychobiology. 2012;66(2):77–92. doi: http://dx.doi.org/10.1159/000339456. PubMed DOI

Warner L, Mariathasan J, Lawton-Smith S, Samele C. Choice literature review. London: Kings Fund/Sainsbury Centre for Mental Health; 2006.

Witt K, van Dorn R, Fazel S. Risk factors for violence in psychosis: systematic review and meta-regression analysis of 110 studies. PLoS One. 2013;8(2):e55942. PubMed PMC

Wigman JTW, Collip D, Wichers M, et al. Altered Transfer of Momentary Mental States (ATOMS) as the Basic Unit of Psychosis Liability in Interaction with Environment and Emotions. PLoS ONE. 2013;8(2):1–11. PubMed PMC

Wood SJ, Yung AR, McGorry PD, Pantelis C. Neuroimaging and Treatment Evidence for Clinical Staging in Psychotic Disorders: From the At-Risk Mental State to Chronic Schizophrenia. Biological Psychiatry. 2011;70(7):619–625. PubMed

Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry. 2013;70:913–920. PubMed

Yang Z, Zuo XN, Wang P, et al. Generalized RAICAR: Discover homogeneous subject (sub)groups by reproducibility of their intrinsic connectivity networks. NeuroImage. 2012;63(1):403–414. PubMed

Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. Journal of neurology. 2011;258(4):686–688. PubMed PMC

Zipursky RB, Menezes NM, Streiner DL. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review. Schizophr Res. 2014;152(2–3):408–414. PubMed

Zubin J, Spring B. Vulnerability–a new view of schizophrenia. J Abnorm Psychol. 1977;86(2):103–126. PubMed

Bipolar Schizophrenia Network on Intermediate Phenotypes (BSNIP) Consortium. www.b-snip.org.

Cognitive Neuroscience Task Reliability & Clinical Applications (CNTRACs) Consortium. http://cntracs.ucdavis.edu/